Sergio Raposeiras-Roubín to Male
This is a "connection" page, showing publications Sergio Raposeiras-Roubín has written about Male.
Connection Strength
0.134
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020 Oct; 9(7):764-770.
Score: 0.011
-
Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor. Thromb Res. 2019 02; 174:51-58.
Score: 0.011
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
Score: 0.011
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
Score: 0.011
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
Score: 0.010
-
Effect of beta-blocker dose on mortality after acute coronary syndrome. Rev Port Cardiol (Engl Ed). 2018 Mar; 37(3):239-245.
Score: 0.010
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score. Int J Cardiol. 2018 03 01; 254:10-15.
Score: 0.010
-
Prognostic usefulness of an age-adapted equation for renal function assessment in older patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2018 Dec; 7(8):703-709.
Score: 0.010
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Am Heart J. 2021 07; 237:104-115.
Score: 0.003
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing. 2021 02 26; 50(2):326-334.
Score: 0.003
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart. Clin Exp Med. 2021 May; 21(2):249-268.
Score: 0.003
-
Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021; 28(2):202-214.
Score: 0.003
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 06; 16(4):957-966.
Score: 0.003
-
Outcomes of acute coronary syndromes in coronavirus disease 2019. Clin Res Cardiol. 2020 Dec; 109(12):1601-1604.
Score: 0.003
-
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 08; 33(4):737-745.
Score: 0.003
-
Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur Heart J. 2020 06 07; 41(22):2132.
Score: 0.003
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.003
-
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry. Am J Cardiovasc Drugs. 2018 Aug; 18(4):299-309.
Score: 0.003
-
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. Thromb Res. 2018 08; 168:156-163.
Score: 0.003
-
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
Score: 0.003
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018 07; 167:142-148.
Score: 0.003
-
Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients. Rev Esp Cardiol (Engl Ed). 2018 Oct; 71(10):829-836.
Score: 0.003
-
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry. Thromb Haemost. 2018 05; 118(5):929-938.
Score: 0.003
-
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention. 2018 03 20; 13(16):1914-1922.
Score: 0.003
-
Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2018 Jul; 71(7):538-544.
Score: 0.003
-
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. EuroIntervention. 2017 Jul 20; 13(4):407-414.
Score: 0.002